Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma

NCT00515190 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

198

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: S-1,oxaliplatin

Sponsor

National Cancer Center, Korea